- 09-26-2008
- Verax Biomedical Platelet PGD® Test for Bacterial Detection Now CE Marked
- 10-18-2007
- Verax Biomedical Receives ISO Certification
- 09-19-2007
- Verax Biomedical Receives 510 (k) Clearance from FDA for Platelet PGD Test
- 06-15-2007
- Verax Biomedical to Present at Annual ISBT Symposium
- 05-08-2007
- Verax Biomedical Appoints Scott McKenzie and Nancy Hornbaker
- 03-14-2007
- Verax Biomedical Submits 510(k) Application to FDA for Platelet PGD Test
- 01-29-2007
- Verax Biomedical Appoints James Koziarz, Ph.D. to Board of Directors
- 12-18-2006
- Verax Biomedical Taps British Biocell to Manufacture Platelet PGD Tests
- 10-20-2006
- Abbott Signs Exclusive Worldwide Distribution Agreement With Verax Biomedical for Rapid Platelet Bacteria Test
- 09-28-2006
- Verax Biomedical Initiates Two External Clinical Trials
- 09-05-2006
- Verax Biomedical Names Chief Executive Officer
- 10-14-2005
- Verax Biomedical Closes $15 Million Series B Private Placement
Verax Biomedical
Skip to contentNews
The PGD testing system
The Company's first product is the Platelet PGD Test — a rapid QC test for the detection of bacterial contamination in platelets.
